The IBD SmartSelect Composite Rating for Cellebrite DI rose from 94 to 97 Friday.
The upgrade means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength. Winning stocks often have a 95 or higher grade in the early stages of a new price run, so that's a good item to have on your checklist when looking for the best stocks to buy and watch.
Cellebrite DI has now climbed above a proper buy zone after clearing the 12.50 entry in a consolidation.
Lean How — And When — To Sell Stocks
The stock earns a 90 EPS Rating, meaning its recent quarterly and annual earnings growth tops 90% of all stocks.
Its Accumulation/Distribution Rating of A- shows heavy buying by institutional investors, such as mutual funds and pension funds, over the last 13 weeks.
In Q3, the company posted 56% EPS growth. Sales growth climbed 27%, up from 25% in the prior report. That marks one quarter of increasing revenue growth.
Cellebrite DI holds the No. 2 rank among its peers in the Computer Software-Special Enterprise industry group. AppLovin is the No. 1-ranked stock within the group.
